Given that only GRag+EPZ-6438 combinations induced dramatically enhanced anti-proliferative effects, compared to either single agent, in EZH2 mutant and three out of four EZH2 wild-type GCB lymphoma cell lines, we evaluated this combination in greater detail. This evidence concerns the gene EZH2 and lymphoma.